Study: Antibiotic in drug combo could shorten TB treatment

09/18/2007 | Reuters

A combination of Bayer AG's antibiotic moxifloxacin -- in place of an older drug -- with standard tuberculosis drugs may reduce the length of treatment by at least two months, researchers reported. Experts believe that speeding up the six-month therapy can help TB patients follow their prescribed regimens and prevent or reduce the development of drug-resistant strains.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA